2020年度報告

China’s online health platforms boom in wake of coronavirus

Demand for virtual consultations and drug sales driven by gaps in country’s healthcare coverage

Chinese technology groups are vying to lead the country’s fledgling online healthcare sector after the coronavirus pandemic boosted demand for platforms that provide virtual consultations and sell medicines.

Following a decade of tepid uptake for online pharmacies and consultations, Covid-19 has prompted a clamour for remote healthcare services by patients afraid to visit hospitals and investors keen to tap into the expanding sector. Digital alternatives could also potentially fill longstanding gaps in China’s healthcare coverage, where the best doctors and equipment are concentrated in top-tier hospitals in big cities.

The growing interest in the industry was underscored last week when shares in JD Health rose as much as 75 per cent on their debut. The healthcare unit of ecommerce group JD.com earlier raised $3.5bn in Hong Kong’s biggest initial public offering of 2020.

您已閱讀21%(881字),剩餘79%(3346字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×